April 2011
Volume 52, Issue 14
Free
ARVO Annual Meeting Abstract  |   April 2011
Retinal Function Imaging for Evaluating of Changes in Retinal Blood Flow after Pan-retinal Laser Photocoagulation in Patients with Proliferative Diabetic Retinopathy
Author Affiliations & Notes
  • Chavakij BHOOMIBUNCHOO
    Retina Center, The New York Eye & Ear Infrimary, New York, New York
  • Nicole Scripsema
    Retina Center, The New York Eye & Ear Infrimary, New York, New York
  • Gennady Landa
    Retina Center, The New York Eye & Ear Infrimary, New York, New York
  • Richard B. Rosen
    Retina Center, The New York Eye & Ear Infrimary, New York, New York
    Dept. of Ophthalmology, New York Medical College, Valhalla, New York
  • Footnotes
    Commercial Relationships  Chavakij Bhoomibunchoo, None; Nicole Scripsema, None; Gennady Landa, None; Richard B. Rosen, OPCO (F), Topcon Medical System, Inc (F)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 2902. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chavakij BHOOMIBUNCHOO, Nicole Scripsema, Gennady Landa, Richard B. Rosen; Retinal Function Imaging for Evaluating of Changes in Retinal Blood Flow after Pan-retinal Laser Photocoagulation in Patients with Proliferative Diabetic Retinopathy. Invest. Ophthalmol. Vis. Sci. 2011;52(14):2902.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: : Retinal function imaging for evaluating of changes in retinal blood flow following pan-retinal laser photocoagulation in patients with proliferative diabetic retinopathy.

Methods: : To evaluate the effect of pan-retinal laser photocoagulation (PRP) on retinal blood flow in eyes with proliferative diabetic retinopathy (PDR) using the Retinal Function Imager (RFI).

Results: : 20 eyes were enrolled. Mean age was 50.2 +/- 9.36 years (38 to 64 years). The mean venous velocity before PRP treatment was 2.82 +/- 0.61 mm/sec and after PRP treatment was 2.62 +/- 0.37 mm/sec. The results demonstrate a significant decrease in venous velocity following PRP treatment (p value =0.03). The venous velocity decreased by at least 14.04% in these patients. The mean arterial velocity before PRP treatment was 4.48 +/- 1.42 mm/sec and after PRP treatment was 4.46 +/- 1.57 mm/sec. Arterial velocity following PRP treatment showed inconsistent response to PRP treatment.

Conclusions: : The RFI is novel non-invasive imaging system which allows for quantitative analysis of retinal blood flow. The results of this study suggest that PRP treatment may effect retinal blood flow by reducing venous velocity in proliferative diabetic retinopathy patients. Further analysis may help assess the utility of the RFI measurements of response to PRP as an indicator of suppression of PDR activity.

Keywords: imaging/image analysis: clinical • diabetic retinopathy • laser 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×